List of Komodo Health iris Customers
San Francisco, 94107, CA,
United States
Since 2010, our global team of researchers has been studying Komodo Health iris customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Komodo Health iris for Analytics and BI from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Komodo Health iris for Analytics and BI include: McKesson, a United States based Distribution organisation with 45000 employees and revenues of $359.10 billion, Karyopharm Therapeutics, a United States based Life Sciences organisation with 385 employees and revenues of $157.0 million, TrinityLifeSci, a United States based Professional Services organisation with 400 employees and revenues of $38.0 million, Fight Colorectal Cancer, a United States based Non Profit organisation with 23 employees and revenues of $3.0 million and many others.
Contact us if you need a completed and verified list of companies using Komodo Health iris, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Komodo Health iris customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight | Insight Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Fight Colorectal Cancer | Non Profit | 23 | $3M | United States | Komodo Health | Komodo Health iris | Analytics and BI | 2019 | n/a | In 2019 Fight Colorectal Cancer implemented Komodo Health iris as part of a provider identification and outreach initiative to support patient engagement and public health objectives. The project used Komodo Health iris within an Analytics and BI context to build a public-facing Provider Finder and to target outreach aimed at improving screening rates and specialist access across the United States. The deployment emphasized provider-level commercial analytics and geospatial mapping, leveraging Komodo’s Healthcare Map and Aperture capabilities to identify high-impact providers and regions. Komodo Health iris was configured to surface specialty coverage, geographic provider density, and referral pattern signals, supporting prioritization of outreach lists and site-level engagement workflows. Integrations focused on Komodo’s Healthcare Map and Aperture data layers, with outputs routed to the organization’s patient engagement and public-facing content channels. Operational coverage was nationwide, and the solution supported functions including patient navigation, outreach targeting, and care access communications. Governance and rollout followed an iterative validation process, including provider attribution review and public content validation prior to launch. The engagement culminated in a public Provider Finder launched in 2022 to connect colorectal cancer patients with specialists nationwide. | |
 |
Karyopharm Therapeutics | Life Sciences | 385 | $157M | United States | Komodo Health | Komodo Health iris | Analytics and BI | 2020 | n/a | In 2020, Karyopharm Therapeutics engaged Komodo Health iris within the Analytics and BI category to accelerate clinical trial site identification and patient recruitment for a COVID-19 study. The engagement applied Komodo’s Healthcare Map and patient-journey analytics to surface provider-level and patient-level signals for rapid site and provider targeting in the United States. Komodo Health iris was used to operationalize cohort discovery, site feasibility assessment, and provider outreach prioritization for clinical operations and clinical research teams. Deployment centered on analytics and BI workflows, configuring provider and patient attribution models, temporal patient-journey sequencing, and cohort identification logic to support trial enrollment workflows. Operational scope focused on clinical operations and site selection within the United States, with outputs handed to study teams for recruitment and outreach execution. The collaboration supported accelerated site identification and patient recruitment as part of the 2020 COVID-19 trial effort. | |
 |
McKesson | Distribution | 45000 | $359.1B | United States | Komodo Health | Komodo Health iris | Analytics and BI | 2019 | n/a | In 2019, McKesson deployed Komodo Health iris as part of its Analytics and BI portfolio to augment population-level clinical analytics for its distribution and healthcare services operations. Komodo Health iris provides an analytics-powered healthcare map together with machine learning capabilities to surface patient population insights for pharmaceutical stakeholders and clinician-facing workflows. The implementation centers on anonymized patient data ingestion pipelines that feed model training and an analytics layer, including patient history analysis, clustering algorithms that group similar patients or disease patterns, and correlation discovery between symptoms and outcomes. Komodo Health iris was configured to deliver machine learning model training, predictive analytics modules, and visualization layers typical of Analytics and BI applications to support diagnostic workflows and research use cases. Operational coverage spans McKesson teams focused on pharmaceutical population insights and clinicians seeking diagnostic support, and it underpins oncology research aimed at earlier and more precise cancer prediction. Data governance is anchored in deidentification and privacy preserving controls to protect patient identity while enabling model development, and the platform’s population mapping capability highlights regional disease spread and patient clusters. McKesson uses Komodo Health iris to help doctors leverage past patients’ histories to diagnose current patients, to surface correlations between symptoms and disease, and to cluster similar patients or regional outbreaks. The deployment also supports ongoing efforts to apply Komodo Health iris AI modeling to earlier and more precise cancer prediction. | |
 |
|
Professional Services | 400 | $38M | United States | Komodo Health | Komodo Health iris | Analytics and BI | 2021 | n/a |
|
|
Buyer Intent: Companies Evaluating Komodo Health iris
- TrinityLifeSci, a United States based Professional Services organization with 400 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||